Search Results - "Levin, M. D."

About the Diagnosis of GERD in the Article by Sharma et al. “Esophageal Pathology in Asymptomatic and Symptomatic Patients with Obesity Undergoing Evaluation for Bariatric Surgery” by Levin, M. D.

Get full text

Radiological complete remission in HER2-positive metastatic breast cancer patients: what to do with trastuzumab? by Steenbruggen, T. G., Bouwer, N. I., Smorenburg, C. H., Rier, H. N., Jager, A., Beelen, K., ten Tije, A. J., de Jong, P. C., Drooger, J. C., Holterhues, C., Kitzen, J. J. E. M., Levin, M. -D., Sonke, G. S.

“…Purpose Patients with HER2-positive metastatic breast cancer (MBC) treated with trastuzumab may experience durable tumor response for many years. It is unknown…”
Get full text

Cardiotoxicity during long-term trastuzumab use in patients with HER2-positive metastatic breast cancer: who needs cardiac monitoring? by Bouwer, N. I., Steenbruggen, T. G., van Rosmalen, J., Rier, H. N., Kitzen, J. J. E. M., van Bekkum, M. L., Tije, A. J. Ten, de Jong, P. C., Drooger, J. C., Holterhues, C., Smorenburg, C. H., Kofflard, M. J. M., Boersma, E., Sonke, G. S., Levin, M.-D., Jager, A.

“…Purpose Patients with HER2-positive metastatic breast cancer (MBC) usually receive many years of trastuzumab treatment. It is unknown whether these patients…”
Get full text

Early-stage measurable residual disease dynamics and IGHV repertoire reconstitution during venetoclax and obinutuzumab treatment in chronic lymphocytic leukemia by Hengeveld, P. J., Schilperoord-Vermeulen, J., van der Klift, M. Y., Dubois, J. M. N., Kolijn, P. M., Kavelaars, F. G., Rijken, M., Dobber, J. A., Nasserinejad, K., Kersting, S., Westerweel, P. E., Kater, A. P., Langerak, A. W., Levin, M-D.

Get full text

Examination of peripheral blood smears: performance evaluation of a digital microscope system using a large-scale leukocyte database by Stouten, K., Riedl, J. A., Levin, M.-D., van Gelder, W.

Get full text

PB1886: LONG‐TERM TRENDS IN THE LOSS OF LIFE EXPECTANCY AFTER A DIAGNOSIS OF CHRONIC LYMPHOCYTIC LEUKEMIA: A POPULATION‐BASED STUDY IN THE NETHERLANDS, 1989‐2018 by Van Der Straten, L., Maas, C. C., Levin, M.‐D., Visser, O., Posthuma, E. F., Doorduin, J. K., Langerak, A. W., Kater, A. P., Dinmohamed, A. G.

Get full text

Sphincter Ochsner dyskinesia as a cause of superior mesenteric artery syndrome by Levin, M D

“…to investigate the pathological physiology of superior mesenteric artery syndrome (SMAS). We selected 35 articles devoted to SMAS, which were published from…”
Get full text

Blue sclerae: diagnosis at a glance by Crop, M J, Ramdas, W D, Levin, M-D

Get full text

P933: DARATUMUMAB (D) IN COMBINATION WITH VD OR D‐RD IN RELAPSED OR REFRACTORY MULTIPLE MYELOMA: SUBGROUP ANALYSIS OF CASTOR AND POLLUX STUDIES IN PATIENTS WITH EARLY OR LATE RELAPSE AFTER INITIAL THERAPY by Spencer, A., Moreau, P., Mateos, M.‐V., Goldschmidt, H., Suzuki, K., Levin, M.‐D., Sonneveld, P., Yoon, S.‐S., Usmani, S. Z., Weisel, K., Reece, D., Ahmadi, T., Pei, H., Garvin Mayo, W., Gai, X., Carey, J., Carson, R., Dimopoulos, M. A.

Get full text

P609: CLINICOBIOLOGICAL CHARACTERISTICS AND TREATMENT EFFICACY OF NOVEL AGENTS IN CHRONIC LYMPHOCYTIC LEUKEMIA WITH IGLV3‐21R110 by Hengeveld, P., Ertem, Y. E., Dubois, J., Mellink, C., Kevie‐Kersemaekers, A.‐M., Evers, L., Heezen, K., Kolijn, P. M., Mook, O., Motazacker, M. M., Nasserinejad, K., Kersting, S., Westerweel, P., Niemann, C., Kater, A., Langerak, A., Levin, M.‐D.

Get full text

P652: MEASURING MINIMAL RESIDUAL DISEASE BEYOND 10‐4 THROUGH IGHV LEADER‐BASED NEXT GENERATION SEQUENCING IMPROVES PROGNOSTIC STRATIFICATION IN CHRONIC LYMPHOCYTIC LEUKEMIA by Hengeveld, P., Klift, M., Kolijn, P. M., Davi, F., Kavelaars, F., Jonge, E., Robrecht, S., Assmann, J., Straten, L., Ritgen, M., Westerweel, P., Fischer, K., Goede, V., Hallek, M., Levin, M.‐D., Langerak, A.

Get full text

P905: IXAZOMIB‐THALIDOMIDE‐DEXAMETHASONE INDUCTION FOLLOWED BY IXAZOMIB OR PLACEBO MAINTENANCE IN NON‐TRANSPLANT ELIGIBLE NEWLY DIAGNOSED MULTIPLE MYELOMA PATIENTS; LONG‐TERM RESULTS OF HOVON‐126/NMSG 21.13 by Groen, K., Seefat, M. R., Holt, B., Schjesvold, F. H., Stege, C. A., Levin, M.‐D., Hansson, M., Leys, R. B., Regelink, J., Waage, A., Szatkowski, D., Axelsson, P., Do, T. H., Svirskaite, A., Spek, E., Haukas, E., Knut‐Bojanowska, D., Ypma, P. F., Blimark, C., Mellqvist, U.‐H., Donk, N. W., Sonneveld, P., Klostergaard, A., Vangsted, A. J., Abdilgaard, N., Zweegman, S.

Get full text

P906: IXAZOMIB, DARATUMUMAB AND LOW DOSE DEXAMETHASONE IN FRAIL PATIENTS WITH NEWLY DIAGNOSED MULTIPLE MYELOMA (NDMM): RESULTS OF THE MAINTENANCE TREATMENT OF THE PHASE II HOVON 143 STUDY by Groen, K., Seefat, M., Nasserinejad, K., Stege, C. A., Spek, E., Bilgin, Y. M., Kentos, A., Sohne, M., Kampen, R. J., Ludwig, I., Thielen, N., Durdu‐Rayman, N., Graauw, N. C., Donk, N. W., Waal, E. G., Vekemans, M.‐C., Timmers, G. J., Klift, M., Soechit, S., Geerts, P. A., Silbermann, M. H., Oosterveld, M., Nijhof, I., Sonneveld, P., Klein, S. K., Levin, M.‐D., Zweegman, S.

Get full text

Design of Organic Molecules with Large Two-Photon Absorption Cross Sections by Albota, Marius, Beljonne, David, Brédas, Jean-Luc, Ehrlich, Jeffrey E., Fu, Jia-Ying, Heikal, Ahmed A., Hess, Samuel E., Kogej, Thierry, Levin, Michael D., Marder, Seth R., McCord-Maughon, Dianne, Perry, Joseph W., Röckel, Harald, Rumi, Mariacristina, Subramaniam, Girija, Webb, Watt W., Wu, Xiang-Li, Xu, Chris

“…A strategy for the design of molecules with large two-photon absorption cross sections, δ, was developed, on the basis of the concept that symmetric charge…”
Get full text

Receptor clustering as a cellular mechanism to control sensitivity by Bray, Dennis, Levin, Matthew D, Morton-Firth, Carl J

“…Chemotactic bacteria such as Escherichia coli can detect and respond to extremely low concentrations of attractants, concentrations of less than 5 nM in the…”
Get full text

Enteroviral encephalitis in a patient with a marginal zone lymphoma treated with rituximab by SCHILTHUIZEN, C, BERENSCHOT, H. W. A, LEVIN, M.-D

Get full text

Noise in gene expression as the source of non-genetic individuality in the chemotactic response of Escherichia coli by Levin, M.D.

“…A deterministic computer model of the signal transduction pathway mediating bacterial chemotaxis was used to examine the variation in both unstimulated…”
Get full text

Quality of life gains in frail and intermediate-fit patients with multiple Myeloma: Findings from the prospective HOVON123 clinical trial by Seefat, M.R., Stege, C.A.M., Lissenberg-Witte, B.I., Levin, M.D., Timmers, G.J., Hoogendoorn, M., Ypma, P.F., Klein, S.K., Velders, G.A., Westerman, M., Strobbe, L., Durdu-Rayman, N., Davidis-van Schoonhoven, M.A., van Kampen, R.J.W., Dijk, A.C., Koster, A., Silbermann, M.H., van der Spek, E., Beeker, A., Erjavec, Z., de Graauw, N.C.H.P., Leys, M.B.L., Sonneveld, P., van de Donk, N.W.C.J., Nasserinejad, K., Blommestein, H.M., Cucchi, D.G.J., Zweegman, S.

“…Frailty in newly-diagnosed multiple myeloma (NDMM) patients is associated with treatment-related toxicity, which negatively affects health-related quality of…”
Get full text

Crystallographic Texture and Functional Properties of Powder Titanium Alloys after Thermomechanical Treatment by Markova, G. V., Ivankina, T. I., Levin, D. M., Volodko, S. S.

“…A relationship is established between the crystallographic texture developed during various thermomechanical treatments and the functional properties of…”
Get full text

Disseminated intravascular coagulation and a negative D-dimer test by CONSTANTINESCU, A. A, BERENDES, P. B, LEVIN, M.-D

“…The diagnosis of disseminated intravascular coagulation (DIC) requires the presence of a fibrin-related marker. D-dimer is frequently used in clinical practice…”
Get full text